GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CareDx Inc (FRA:1K9) » Definitions » Cyclically Adjusted Revenue per Share

CareDx (FRA:1K9) Cyclically Adjusted Revenue per Share : €3.74 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is CareDx Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CareDx's adjusted revenue per share for the three months ended in Jun. 2024 was €1.642. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €3.74 for the trailing ten years ended in Jun. 2024.

During the past 12 months, CareDx's average Cyclically Adjusted Revenue Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-09-27), CareDx's current stock price is €25.71. CareDx's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was €3.74. CareDx's Cyclically Adjusted PS Ratio of today is 6.87.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of CareDx was 7.57. The lowest was 1.22. And the median was 2.58.


CareDx Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for CareDx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareDx Cyclically Adjusted Revenue per Share Chart

CareDx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.55 3.93

CareDx Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 3.84 3.93 3.84 3.74

Competitive Comparison of CareDx's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, CareDx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareDx's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CareDx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CareDx's Cyclically Adjusted PS Ratio falls into.



CareDx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CareDx's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=1.642/132.5538*132.5538
=1.642

Current CPI (Jun. 2024) = 132.5538.

CareDx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 0.460 100.428 0.607
201412 0.527 99.070 0.705
201503 0.564 99.621 0.750
201506 0.537 100.684 0.707
201509 0.536 100.392 0.708
201512 0.513 99.792 0.681
201603 0.492 100.470 0.649
201606 0.704 101.688 0.918
201609 0.571 101.861 0.743
201612 0.483 101.863 0.629
201703 0.507 102.862 0.653
201706 0.501 103.349 0.643
201709 0.454 104.136 0.578
201712 0.377 104.011 0.480
201803 0.385 105.290 0.485
201806 0.429 106.317 0.535
201809 0.489 106.507 0.609
201812 0.515 105.998 0.644
201903 0.553 107.251 0.683
201906 0.661 108.070 0.811
201909 0.724 108.329 0.886
201912 0.759 108.420 0.928
202003 0.811 108.902 0.987
202006 0.830 108.767 1.012
202009 0.924 109.815 1.115
202012 0.977 109.897 1.178
202103 1.106 111.754 1.312
202106 1.179 114.631 1.363
202109 1.220 115.734 1.397
202112 1.326 117.630 1.494
202203 1.360 121.301 1.486
202206 1.432 125.017 1.518
202209 1.498 125.227 1.586
202212 1.453 125.222 1.538
202303 1.345 127.348 1.400
202306 1.205 128.729 1.241
202309 1.162 129.860 1.186
202312 1.126 129.419 1.153
202403 1.282 131.776 1.290
202406 1.642 132.554 1.642

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


CareDx  (FRA:1K9) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

CareDx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=25.71/3.74
=6.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of CareDx was 7.57. The lowest was 1.22. And the median was 2.58.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CareDx Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of CareDx's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CareDx Business Description

Industry
Traded in Other Exchanges
Address
8000 Marina Boulevard, Brisbane, CA, USA, 94005
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

CareDx Headlines

No Headlines